ロード中...
An Unusual Etiology of Graves’ Disease: Alemtuzumab
Cluster of differentiation 52 (CD-52) is a glycoprotein expressed on the surface of most lymphocytes and it is the most prevalent marker in T cells, B cells, natural killers and monocytes. Alemtuzumab, a CD-52 monoclonal antibody, is one of the initial therapies approved for patients with relapsing-...
保存先:
| 出版年: | J Endocr Soc |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089799/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1882 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|